Literature DB >> 19499228

[Treatment of chronic blepharokeratoconjunctivitis with local calcineurin inhibitors].

C Auw-Hädrich1, T Reinhard.   

Abstract

Topical calcineurin inhibitors (cyclosporin A 1%, FK506, pimecrolimus) can be useful for treating chronic blepharokeratoconjunctivitis in addition to lid hygiene and lubricants. This treatment leads to an improvement of dry eye symptoms and reduces inflammation.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19499228     DOI： 10.1007/s00347-009-1954-9

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


  11 in total

1.  Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction.

Authors:  Henry D Perry; Sima Doshi-Carnevale; Eric D Donnenfeld; Renée Solomon; Seth A Biser; Adam H Bloom
Journal:  Cornea       Date:  2006-02       Impact factor: 2.651

2.  Prolonged exposure to topical cyclosporine A does not seem to promote conjunctival malignancy.

Authors:  Daniel Böhringer; Bartosz Wojanowski; Thomas Reinhard
Journal:  Acta Ophthalmol       Date:  2007-11-17       Impact factor: 3.761

3.  Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis.

Authors:  E Nivenius; I van der Ploeg; K Jung; E Chryssanthou; M van Hage; P G Montan
Journal:  Eye (Lond)       Date:  2006-05-05       Impact factor: 3.775

4.  Efficacy of topical cyclosporin 0.05% in the treatment of posterior blepharitis.

Authors:  Michael Rubin; Sanjay N Rao
Journal:  J Ocul Pharmacol Ther       Date:  2006-02       Impact factor: 2.671

5.  [Topical Fk506 in inflammatory corneal and conjunctival diseases. A pilot study].

Authors:  Thomas Reinhard; Alexander Reis; Susanne Mayweg; Hermann Oberhuber; Georg Mathis; Rainer Sundmacher
Journal:  Klin Monbl Augenheilkd       Date:  2002-03       Impact factor: 0.700

6.  Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study.

Authors:  Hannele M Virtanen; Sakari Reitamo; Marjatta Kari; Osmo Kari
Journal:  Acta Ophthalmol Scand       Date:  2006-10

7.  Topical cyclosporin A in Thygeson's superficial punctate keratitis.

Authors:  T Reinhard; R Sundmacher
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1999-02       Impact factor: 3.117

8.  A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis.

Authors:  Esen Karamursel Akpek; John K Dart; Stephanie Watson; William Christen; Dilek Dursun; Sonia Yoo; Terrence P O'Brien; Oliver D Schein; John D Gottsch
Journal:  Ophthalmology       Date:  2004-03       Impact factor: 12.079

9.  A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis.

Authors:  M Hingorani; L Moodaley; V L Calder; R J Buckley; S Lightman
Journal:  Ophthalmology       Date:  1998-09       Impact factor: 12.079

Review 10.  Use of pimecrolimus cream in disorders other than atopic dermatitis.

Authors:  Isaiah Day; Andrew N Lin
Journal:  J Cutan Med Surg       Date:  2008 Jan-Feb       Impact factor: 2.092
View more
  6 in total

Review 1.  [Immunosuppressives to prevent rejection reactions after allogeneic corneal transplantation].

Authors:  T Lapp; P Maier; F Birnbaum; G Schlunck; T Reinhard
Journal:  Ophthalmologe       Date:  2014-03       Impact factor: 1.059

Review 2.  The pathophysiology, diagnosis, and treatment of dry eye disease.

Authors:  Elisabeth M Messmer
Journal:  Dtsch Arztebl Int       Date:  2015-01-30       Impact factor: 5.594

Review 3.  [Treatment options for chronic blepharitis considering current evidence].

Authors:  C Auw-Hädrich; T Reinhard
Journal:  Ophthalmologe       Date:  2016-12       Impact factor: 1.059

Review 4.  Topical treatments for blepharokeratoconjunctivitis in children.

Authors:  Michael O'Gallagher; Catey Bunce; Melanie Hingorani; Frank Larkin; Stephen Tuft; Annegret Dahlmann-Noor
Journal:  Cochrane Database Syst Rev       Date:  2017-02-07

Review 5.  [Ocular involvement in atopic dermatitis : Clinical aspects and therapy].

Authors:  P Maier; T Lapp; T Reinhard
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

6.  Blepharokeratoconjunctivitis in childhood: corneal involvement and visual outcome.

Authors:  A Rodríguez-García; S González-Godínez; S López-Rubio
Journal:  Eye (Lond)       Date:  2015-12-04       Impact factor: 3.775
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.